PENTAVAC

This brand name is authorized in Finland, France

Active ingredients

The drug PENTAVAC contains a combination of these active pharmaceutical ingredients (APIs):

1 Diphtheria toxoid purified
UNII 3U7E3O07S8 - CORYNEBACTERIUM DIPHTHERIAE
Read about Diphtheria toxoid
2 Tetanus toxoid purified
UNII K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Tetanus toxoid
3 Pertussis toxoid purified (PT XD)
Read about Pertussis toxoid
4 Filamentous haemagglutinin (FHA)
UNII 8C367IY4EY - BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Pertussis filamentous hemagglutinin
5 Inactivated poliovirus vaccine type I
UNII 0LVY784C09 - POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Poliomyelitis, serotype 1
6 Inactivated poliovirus vaccine type II
UNII 23JE9KDF4R - POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Poliomyelitis, serotype 2
7 Inactivated poliovirus vaccine type III
UNII 459ROM8M9M - POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Poliomyelitis, serotype 3
8 Haemophilus type b polysaccharide conjugate to tetanus protein
UNII FLV5I5W26R - HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN

Haemophilus influenza type B (Hib) is a bacteria responsible for severe pneumonia, meningitis and other invasive diseases almost exclusively in young children. Vaccines are the only public health tool capable of preventing the majority of serious Hib disease.

Read about Haemophilus influenzae B

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J07CA06 Diphtheria-Haemophilus influenzae B-pertussis-poliomyelitis-tetanus J Antiinfectives for systemic use → J07 Vaccines → J07C Bacterial and viral vaccines, combined → J07CA Bacterial and viral vaccines, combined
Discover more medicines within J07CA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 028333, 169734
Country: FR Base de données publique des médicaments Identifier(s): 69811279

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈